. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
subsidiary’s total net profit decreased by Baht 1,468 million or 75% while total revenue from sales and services increased by Baht 1,850 million or 29%. Raw material cost and cash conversion cost increase higher
raw material and cash conversion cost. On a YoY basis, the Company and subsidiary’s total net loss increased by Baht 666 million or 91% while total revenue from sales and services increased by Baht
sales and services amounted to Baht 8,678 million, increased by Baht 863 million or 11% QoQ. Revenue increase came from sale volume increase but still had net loss because raw material cost increase
Industrial water, Chilled water, Nitrogen and Others Unit: Million Baht Unit: Million Baht Natural gas(IPP) Natural gas (SPP+VSPP) Other raw materials Coal Maintenance costs Others 51% 54% 51% 19% 19% 29% 28
water, Chilled water, Nitrogen and Others Unit: Million Baht Unit: Million Baht Natural gas(IPP) Natural gas (SPP+VSPP) Other raw materials Coal Maintenance costs Others Comparing Q3/2019 vs Q2/2019
Plant compared to 2017. Electricity (SPP+VSPP+Other) Steam Natural gas (IPP) Electricity+ Revenue from finance lease agreement (IPP) Revenue (THB million) Natural gas (SPP) Maintenance fee Other raw
location of the project to reduce the distance for raw material (Vinasses water) transportation from the Biofuel Mitrphol Factory, Dan Chang From the study of the dept cost structure of the transportation